• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Varian Medical revenues soar as company closes fiscal year

Article

Strong demand for new radiation therapy and x-ray imaging products boosted fiscal year 2004 to record earnings, revenues, net orders, and a strong year-ending backlog for Varian Medical Systems. The company, which reported flat orders in Q3 for oncology equipment from North American customers, raised its guidance for fiscal 2005, predicting an increase of 13% to 14% and a rise in earnings of nearly 20% over 2004.

Strong demand for new radiation therapy and x-ray imaging products boosted fiscal year 2004 to record earnings, revenues, net orders, and a strong year-ending backlog for Varian Medical Systems. The company, which reported flat orders in Q3 for oncology equipment from North American customers, raised its guidance for fiscal 2005, predicting an increase of 13% to 14% and a rise in earnings of nearly 20% over 2004.

Net earnings grew about 18% in the fourth quarter ended Sept. 30, to $52 million compared with $44 million in the previous year's fourth quarter. Net earnings for fiscal year 2004 were up 28% to $167 million versus net earnings of $131 million for fiscal year 2003. Fourth-quarter revenues were $345 million, up 14% from the year-ago quarter, bringing revenues for the fiscal year to $1.2 billion, 19% higher than total revenues for fiscal year 2003. Net orders were $412 million for the fourth quarter, up 28% from the year-ago quarter. Total net orders for fiscal year 2004 were $1.4 billion, up 21% from the fiscal year 2003 total. The backlog at year's end was $970 million, 20% higher than at the end of fiscal year 2003.

Oncology Systems revenues for the fiscal year were $1 billion, up 20% from fiscal year 2003. Net orders for the quarter accounted for $351 million, up 24% from the same period last year, and $1.2 billion for the fiscal year, up 20% from fy 2003 totals. Net orders for the year were up 10% in North America and 37% in international markets.

Revenues for the X-Ray Products business, including tubes and amorphous silicon flat-panel digital imagers, were $45 million in the fourth quarter, up 21% from the year-ago quarter. For fy 2004, X-Ray revenues were a record $165 million, up 8% from fiscal year 2003.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.